Altrafin AG’s Bank of America BAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-221,930
Closed -$8.83M 51
2024
Q2
$8.83M Buy
221,930
+8,930
+4% +$342K 3.26% 8
2024
Q1
$8.08M Sell
213,000
-2,000
-0.9% -$68.7K 2.93% 10
2023
Q4
$7.24M Sell
215,000
-200
-0.1% -$5.82K 2.79% 12
2023
Q3
$5.89M Buy
215,200
+64,870
+43% +$1.92M 2.57% 10
2023
Q2
$4.31M Sell
150,330
-330
-0.2% -$9.42K 1.94% 20
2023
Q1
$4.31M Buy
150,660
+3,330
+2% +$110K 2.12% 22
2022
Q4
$4.88M Buy
147,330
+815
+0.6% +$28.1K 2.86% 9
2022
Q3
$4.42M Buy
146,515
+2,625
+2% +$87.8K 2.65% 11
2022
Q2
$4.48M Sell
143,890
-2,500
-2% -$90K 2.42% 13
2022
Q1
$6.03M Buy
146,390
+1,260
+0.9% +$56.9K 2.37% 11
2021
Q4
$6.46M Buy
+145,130
New +$6.61M 2.33% 17

Other funds holding BAC

Altrafin AG's BAC Position: Q3 2024 in Review

Altrafin AG sold out of Bank of America (BAC) in Q3 2024, closing a stake of 221,930 shares — an estimated $8.83M sold.

Altrafin AG first reported a position in BAC in Q4 2021 and held it in 11 quarters. The position peaked at $8.83M in Q2 2024. 2,979 funds tracked by Wall St. Rank hold BAC as of Q3 2024.

  • Altrafin AG reported no remaining Bank of America position as of Q3 2024 after selling out during the quarter.
  • Altrafin AG sold 221,930 Bank of America shares in Q3 2024, an estimated $8.83M.
  • Altrafin AG first reported a position in Bank of America in Q4 2021 and held it in 11 quarters.
  • Altrafin AG's Bank of America position peaked at $8.83M in Q2 2024.
  • 2,979 funds tracked by Wall St. Rank held Bank of America as of Q3 2024.

Based on Altrafin AG's 13F filing for Q3 2024, filed 17 Feb 2026.